-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Can We Move Toward a Precision Medicine Approach for the Treatment of Higher Risk Myelodysplastic Syndromes

Program: How I Treat: Bringing Science to Clinical Dilemmas
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Diseases
Saturday, December 10, 2022: 8:00 AM-9:00 AM
Marlborough A (Hilton New Orleans Riverside)
Olatoyosi Odenike, MD, University of Chicago
No relevant conflicts of interest to declare.